Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation

Transplantation

Volumn 75, Issue 4, 2003, Pages 477-482

  Le Bas Bernardet, Stéphanie ^a   Hourmant, Maryvonne ^b,c   Valentin, Nathalie ^b   Paitier, Catherine ^a   Giral Classe, Magali ^b   Curry, Sylvie ^a   Follea, Gilles ^a   Soulillou, Jean Paul ^b   Bignon, Jean Denis ^a  

^a Centre Regional de Transfusion Sanguine   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; HLA A ANTIGEN; HLA ANTIBODY; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ANTIBODY; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD11A; MONOCLONAL ANTIBODY CD3; OKT 4; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN SPECIFICITY; ARTICLE; B CELL CROSSMATCH; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HLA TYPING; HUMAN; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AUTOANTIBODIES; B-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0037468391     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000047311.77702.59     Document Type: Article

References (28)

1. Ettenger RB, Terasaki PI, Opelz G, et al. Successful renal allograft across a positive cross-match against donor B-lymphocyte alloantigen. Lancet 1976; 2: 56.
2. Morrow CE, Sutherland DE, Fryd DS, et al. Renal allograft survival in patients with a positive B cell crossmatch to their donor. Ann Surg 1984; 199: 75.
3. Noreen H, van der Hagen E, Najarian JS, et al. Renal allograft survival in CsA-treated patients with positive donor-specific B cell crossmatches. Transplant Proc 1989; 21: 691.
4. Opelz G. Relevance of remote positive crossmatch and positive B cell crossmatch in renal transplantation. Transplant Proc 1990; 22: 1876.
5. Ahern AT, Artruc SB, Della Pelle P, et al. Hyperacute rejection of HLA-A, B identical renal allograft associated with B lymphocyte and endothelial reactive antibodies. Transplantation 1982; 33: 103.
6. Scornick JC, Lefor WM, Cicciarelli JC, et al. Hyperacute and acute kidney graft rejection due to antibodies against B cells. Transplantation 1992; 54: 61.
7. Jeannet M, Benzonana G, Arni I. Donor-specific B and T lymphocyte antibodies and kidney graft survival. Transplantation 1981; 31: 160.
8. Ting A. Positive crossmatches. When is it safe to transplant? Transpl Int 1989; 2: 2.
9. Guerin C, Pommier G, Fleuru H, et al. Renal transplantation with positive allocrossmatch (B/T; historical/current) but current T negative. Transplant Proc 1991; 23: 417.
10. Jendrisak M, Phelan D, Marsh J, et al. Significance of B-cell crossmatch on outcome in renal transplantation. Transplant Proc 1991; 23: 434.
11. Hourmant M, Bignon JD, Cesbron A, et al. Effect of a positive crossmatch against donor B lymphocytes in cadaver kidney transplantation. A prospective one-center study. In: Terasaki PI, ed. Clinical Transplants, UCLA Histocompatibility Typing. Los Angeles, Laboratory Press 1990, 301.
12. Phelan DL, Rodey GE, Flye MW, et al. Positive B cell crossmatches: specificity of antibody and graft outcome. Transplant Proc 1989; 21: 687.
13. Sumitran-Karuppan S, Lindholm A, Möller E. Characterization and significance of donor-reactive B cell antibodies in current sera of kidney transplant patients. Transplantation 1990; 49: 510.
14. Ten Hoor G, Coopmans M, Allebes WA. Specificity and Ig class of preformed alloantibodies causing a positive crossmatch in renal transplantation. The implications for graft survival. Transplantation 1993; 56: 298.
15. Ettenger RB, Jordan SC, Fine RN. Cadaver renal transplant outcome in recipients with autolymphocytotoxic antibodies. Transplantation 1983; 35: 429.
16. Ting A, Morris PJ. Successful transplantation with a positive T and B cell crossmatch due to autoreactive antibodies. Tissue Antigens 1983; 21: 219.
17. Soulillou JP, Cantarovich D, Le Mauff B, et al. Randomized trial of an anti-interleukin 2 receptor monoclonal antibody (33B3-1) versus rabbit anti-thymocyte globulin (ATG) in prophylaxis of early rejection in human renal transplantation. N Engl J Med 1990; 322: 1175.
18. Terasaki PI, McClelland JD. Microdroplet assay serum cytotoxins. Nature 1964; 204: 998.
19. Vartdal F, Gaudernack G, Funderud S, et al. HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation: a fast and reliable technique. Tissue Antigens 1986; 28: 301.
20. Kao KJ, Scornik JC, Small SJ. Enzyme-linked immunoassay for anti-HLA antibodies: an alternative to panel studies by lymphocytotoxicity. Transplantation 1993; 55: 192.
21. Pei R, Wang G, Tarsitani C, et al. Simultaneous HLA class I and class II antibodies screening with flow cytometry. Hum Immunol 1998; 59: 313.
22. Buellow R, Chiang T-R, Monteiro F, et al. Soluble HLA antigens and ELISA-A new technology for crossmatch test. Transplantation 1995; 60: 1594.
23. Mueller-Eckhardt G, Kieffel V, Schmidt A, et al. Discrimination of antibodies against antigens on different MHC loci in human sera by specific immobilization of leukocyte antigens. Hum Immunol 1989; 25: 125.
24. Lazda VA. Identification of patients at risk for inferior renal allograft outcome by a strongly positive B cell flow cytometry crossmatch. Transplantation 1994; 57: 964.
25. Ettenger RB, Jordan S, Fine RN. Autolymphocytotoxic antibodies in patients on dialysis awaiting renal transplantation. Transplantation 1981; 32: 248.
26. Lobo P. Nature of autolymphocytotoxins present in renal haemodialysis patients. Transplantation 1981; 32: 233.
27. Ettenger RB, Robertson L. The evaluation and relevance of autolymphocytotoxic antibody in the highly presensitized patient. Transplantation 1987; 43: 302.
28. D'Apice AJ, Tait BD. Most positive B cell crossmatches are not caused by anti-HLA-DR antibodies. Transplantation 1980; 30: 382.